Quarterly report pursuant to Section 13 or 15(d)

Acquisition of Emerald Health Therapeutics, Inc. - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)

v3.22.2.2
Acquisition of Emerald Health Therapeutics, Inc. - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details) - Emerald Health Therapeutics, Inc.
9 Months Ended
Sep. 30, 2022
Stock options  
Class of Warrant or Right [Line Items]  
Dividend yield 0.00%
Volatility, minimum 89.45%
Volatility, maximum 126.82%
Risk-free interest rate, minimum 2.79%
Risk-free interest rate, maximum 4.25%
Minimum | Stock options  
Class of Warrant or Right [Line Items]  
Expected term (years) 21 days
Maximum | Stock options  
Class of Warrant or Right [Line Items]  
Expected term (years) 4 years 11 months 8 days
Dividend yield | EHT Warrants  
Class of Warrant or Right [Line Items]  
Warrants and rights outstanding measurement input 0.0000
Volatility factor | EHT Warrants | Minimum  
Class of Warrant or Right [Line Items]  
Warrants and rights outstanding measurement input 1.006
Volatility factor | EHT Warrants | Maximum  
Class of Warrant or Right [Line Items]  
Warrants and rights outstanding measurement input 1.204
Risk-free interest rate | EHT Warrants | Minimum  
Class of Warrant or Right [Line Items]  
Warrants and rights outstanding measurement input 0.0396
Risk-free interest rate | EHT Warrants | Maximum  
Class of Warrant or Right [Line Items]  
Warrants and rights outstanding measurement input 0.0423
Expected term (years) | EHT Warrants | Minimum  
Class of Warrant or Right [Line Items]  
Expected term (years) 8 months 1 day
Expected term (years) | EHT Warrants | Maximum  
Class of Warrant or Right [Line Items]  
Expected term (years) 2 years 4 months 17 days